findmyKOL
Clinical trialNCT05324683Active, not recruitingObservational

ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)

SponsorIHF GmbH - Institut für HerzinfarktforschungEnrollment2,000Myocardial Ischemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study aims to assess contemporary practice in OCT use during routine interven-tional practice and to assess the impact of the MLD-MAX algorithm on real-world PCI in a large unselected European all-comer-study cohort.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • David-Manuel Leistner, Prof Dr med

    Universitätsklinikum Frankfurt - Med. Klinik 3 - Kardiologie

    Principal Investigator
  • Thomas Johnson, Dr med

    Bristol Heart Institute

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Universitätsklinikum Frankfurt - Med. Klinik 3 - Kardiologie

    Frankfurt am Main, Germany

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 May 2023
Primary completion
30 Apr 2026
Completion
30 Apr 2026
Last update posted
27 Mar 2026
Registered enrollment
2,000
Registry id
NCT05324683

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.